Impact of Postoperative Neck Radiotherapy Volumes on Long-Term Unstimulated Saliva Flow Following Primary Surgery and Ipsilateral Neck Dissection for Oral Cavity Squamous Cell Carcinoma.
Head Neck.
2025 Mar;47(3):847-855. doi: 10.1002/hed.27988. Epub 2024 Oct 30. PubMed PMID:
39474724; PubMed Central PMCID:
PMC11816541.
The Role of Stereotactic Body Radiotherapy in Oligoprogressive Malignant Disease (RADIANT): Oncologic Outcomes From a Phase 2 Nonrandomized Controlled Trial.
Int J Radiat Oncol Biol Phys.
2025 Feb 1;121(2):292-306. doi: 10.1016/j.ijrobp.2024.09.002. Epub 2024 Sep 11. PubMed PMID:
39270828.
Impact of Surgeon-Radiation Oncology Dyads in Oral Cavity Cancer Outcomes.
Ann Surg Oncol.
2025 Feb;32(2):1270-1279. doi: 10.1245/s10434-024-16385-4. Epub 2024 Oct 28. PubMed PMID:
39467971.
Adaptive Universal Principles for Real-world Observational Studies (AUPROS): an approach to designing real-world observational studies for clinical, epidemiologic, and precision oncology research.
Br J Cancer.
2025 Feb;132(2):139-153. doi: 10.1038/s41416-024-02899-x. Epub 2024 Nov 21. Review. PubMed PMID:
39572762; PubMed Central PMCID:
PMC11746990.
Clinical validation of a tissue-agnostic genome-wide methylome enrichment molecular residual disease assay for head and neck malignancies.
Ann Oncol.
2025 Jan;36(1):108-117. doi: 10.1016/j.annonc.2024.08.2348. Epub 2024 Sep 14. PubMed PMID:
39389887.
Identifying Novel Germline Mutations and Copy Number Variations in Patients With SCLC.
JTO Clin Res Rep.
2024 Dec;5(12):100702. doi: 10.1016/j.jtocrr.2024.100702. eCollection 2024 Dec. PubMed PMID:
39564094; PubMed Central PMCID:
PMC11574802.
Cross-ancestral GWAS identifies 29 novel variants across Head and Neck Cancer subsites.
medRxiv.
2024 Nov 18;. doi: 10.1101/2024.11.18.24317473. PubMed PMID:
39606392; PubMed Central PMCID:
PMC11601725.
Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
Int J Radiat Oncol Biol Phys.
2024 Nov 1;120(3):669-677. doi: 10.1016/j.ijrobp.2024.03.050. Epub 2024 Apr 12. PubMed PMID:
38614279.
Smoking and alcohol by HPV status in head and neck cancer: a Mendelian randomization study.
Nat Commun.
2024 Sep 7;15(1):7835. doi: 10.1038/s41467-024-51679-x. PubMed PMID:
39244563; PubMed Central PMCID:
PMC11380676.
Causes and impact of delays during the COVID-19 pandemic on head and neck cancer diagnosis.
Head Neck.
2024 Sep;46(9):2197-2205. doi: 10.1002/hed.27784. Epub 2024 Apr 25. PubMed PMID:
38665037.
Combined Transcriptome and Circulating Tumor DNA Longitudinal Biomarker Analysis Associates With Clinical Outcomes in Advanced Solid Tumors Treated With Pembrolizumab.
JCO Precis Oncol.
2024 Aug;8:e2400100. doi: 10.1200/PO.24.00100. PubMed PMID:
39178369; PubMed Central PMCID:
PMC11371115.
Chromatin- and nucleosome-associated features in liquid biopsy: implications for cancer biomarker discovery.
Biochem Cell Biol.
2024 Aug 1;102(4):291-298. doi: 10.1139/bcb-2024-0004. Epub 2024 Mar 13. Review. PubMed PMID:
38478957.
Telemedicine-enabled biofeedback electropalatography rehabilitation (TEBER): A pilot study for patients treated with surgery for oral cavity carcinoma.
Head Neck.
2024 Jul;46(7):1737-1751. doi: 10.1002/hed.27721. Epub 2024 Apr 1. PubMed PMID:
38561946.
Early Changes in Tumor-Naive Cell-Free Methylomes and Fragmentomes Predict Outcomes in Pembrolizumab-Treated Solid Tumors.
Cancer Discov.
2024 Jun 3;14(6):1048-1063. doi: 10.1158/2159-8290.CD-23-1060. PubMed PMID:
38393391; PubMed Central PMCID:
PMC11145176.
Prospective manipulation of the gut microbiome with microbial ecosystem therapeutic 4 (MET4) in HPV-related locoregionally-advanced oropharyngeal cancer squamous cell carcinoma (LA-OPSCC) undergoing primary chemoradiation: ROMA2 study.
Br J Cancer.
2024 Jun;130(12):1936-1942. doi: 10.1038/s41416-024-02701-y. Epub 2024 May 7. PubMed PMID:
38714747; PubMed Central PMCID:
PMC11183079.
Transoral Robotic Surgery and Radiation Volume Deintensification in Unknown Primary Squamous Cell Carcinoma of the Neck: The Phase 2 FIND Nonrandomized Controlled Trial.
JAMA Otolaryngol Head Neck Surg.
2024 Jun 1;150(6):463-471. doi: 10.1001/jamaoto.2024.0423. PubMed PMID:
38602692; PubMed Central PMCID:
PMC11009865.
Multimodal detection of molecular residual disease in high-risk locally advanced squamous cell carcinoma of the head and neck.
Cell Death Differ.
2024 Apr;31(4):460-468. doi: 10.1038/s41418-024-01272-y. Epub 2024 Feb 26. PubMed PMID:
38409276; PubMed Central PMCID:
PMC11043441.
Targeting Oral Squamous Cell Carcinoma with Combined Polo-Like-Kinase-1 Inhibitors and γ-Radiation Therapy.
Biomedicines.
2024 Feb 23;12(3). doi: 10.3390/biomedicines12030503. PubMed PMID:
38540116; PubMed Central PMCID:
PMC10968374.
Clinical Validation of Human Papilloma Virus Circulating Tumor DNA for Early Detection of Residual Disease After Chemoradiation in Cervical Cancer.
J Clin Oncol.
2024 Feb 1;42(4):431-440. doi: 10.1200/JCO.23.00954. Epub 2023 Nov 16. PubMed PMID:
37972346; PubMed Central PMCID:
PMC10824379.
Exclusion of persistent mutations in splicing factor genes and isocitrate dehydrogenase 2 improves the prognostic power of molecular measurable residual disease assessment in acute myeloid leukemia.
Haematologica.
2024 Feb 1;109(2):671-675. doi: 10.3324/haematol.2023.283510. PubMed PMID:
37345484; PubMed Central PMCID:
PMC10828788.
The Auto-Lindberg Project: Standardized Target Nomenclature in Radiation Oncology Enables Real-World Data Extraction From Radiation Treatment Plans.
Int J Radiat Oncol Biol Phys.
2024 Jan 1;118(1):268-274. doi: 10.1016/j.ijrobp.2023.08.018. Epub 2023 Aug 21. PubMed PMID:
37611810.
Implication of dental insurance status on patterns of pre-radiation dental extraction and risk of osteoradionecrosis of the jaw in head-and-neck cancer patients.
Oral Oncol.
2023 Oct;145:106527. doi: 10.1016/j.oraloncology.2023.106527. Epub 2023 Jul 25. PubMed PMID:
37499325.
MEDIPIPE: an automated and comprehensive pipeline for cfMeDIP-seq data quality control and analysis.
Bioinformatics.
2023 Jul 1;39(7). doi: 10.1093/bioinformatics/btad423. PubMed PMID:
37402621; PubMed Central PMCID:
PMC10348834.
Circulating tumour DNA kinetics in recurrent/metastatic head and neck squamous cell cancer patients.
Eur J Cancer.
2023 Jul;188:29-38. doi: 10.1016/j.ejca.2023.04.014. Epub 2023 Apr 20. PubMed PMID:
37182343.
Effect of Radiation Therapy Quality Assurance on Nasopharyngeal Carcinoma: Usage of a Novel, Web-Based Quality Assurance Application.
Pract Radiat Oncol.
2023 Jul-Aug;13(4):e354-e364. doi: 10.1016/j.prro.2023.03.003. Epub 2023 Mar 21. PubMed PMID:
36948414.
Multi-institutional Prognostic Modeling in Head and Neck Cancer: Evaluating Impact and Generalizability of Deep Learning and Radiomics.
Cancer Res Commun.
2023 Jun;3(6):1140-1151. doi: 10.1158/2767-9764.CRC-22-0152. eCollection 2023 Jun. PubMed PMID:
37397861; PubMed Central PMCID:
PMC10309070.
Human papillomavirus integration transforms chromatin to drive oncogenesis.
Genome Biol.
2023 Jun 27;24(1):142. doi: 10.1186/s13059-023-02926-9. PubMed PMID:
37365652; PubMed Central PMCID:
PMC10294493.
Isolation of salivary cell-free DNA for cancer detection.
PLoS One.
2023;18(5):e0285214. doi: 10.1371/journal.pone.0285214. eCollection 2023. PubMed PMID:
37130100; PubMed Central PMCID:
PMC10153704.
The collateral impact of the COVID-19 pandemic on HPV-positive oropharyngeal cancer diagnosis.
Oral Oncol.
2023 Mar;138:106332. doi: 10.1016/j.oraloncology.2023.106332. Epub 2023 Feb 3. PubMed PMID:
36780824; PubMed Central PMCID:
PMC9894773.
Cell-free DNA methylation-defined prognostic subgroups in small-cell lung cancer identified by leukocyte methylation subtraction.
iScience.
2022 Dec 22;25(12):105487. doi: 10.1016/j.isci.2022.105487. eCollection 2022 Dec 22. PubMed PMID:
36425756; PubMed Central PMCID:
PMC9678731.
The cell-free DNA methylome captures distinctions between localized and metastatic prostate tumors.
Nat Commun.
2022 Oct 29;13(1):6467. doi: 10.1038/s41467-022-34012-2. PubMed PMID:
36309516; PubMed Central PMCID:
PMC9617856.
Cell-free DNA topology depends on its subcellular and cellular origins in cancer.
JCI Insight.
2022 Oct 24;7(20). doi: 10.1172/jci.insight.159590. PubMed PMID:
36125881; PubMed Central PMCID:
PMC9714790.
Evaluation of risk-tailored individualized selection of radiation therapy target volume for head and neck carcinoma of unknown primary.
Radiother Oncol.
2022 Oct;175:56-64. doi: 10.1016/j.radonc.2022.07.016. Epub 2022 Jul 26. PubMed PMID:
35905781.
Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancer.
Head Neck.
2022 Oct;44(10):2181-2196. doi: 10.1002/hed.27139. Epub 2022 Jul 7. PubMed PMID:
35801270.
Sensitive and reproducible cell-free methylome quantification with synthetic spike-in controls.
Cell Rep Methods.
2022 Sep 19;2(9):100294. doi: 10.1016/j.crmeth.2022.100294. eCollection 2022 Sep 19. PubMed PMID:
36160046; PubMed Central PMCID:
PMC9499995.
Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
Cancer.
2022 Aug 1;128(15):2908-2921. doi: 10.1002/cncr.34266. Epub 2022 May 19. PubMed PMID:
35588085.
Nasopharyngeal Carcinoma Radiomic Evaluation with Serial PET/CT: Exploring Features Predictive of Survival in Patients with Long-Term Follow-Up.
Cancers (Basel).
2022 Jun 24;14(13). doi: 10.3390/cancers14133105. PubMed PMID:
35804877; PubMed Central PMCID:
PMC9264840.
Liquid biopsies to predict CDK4/6 inhibitor efficacy and resistance in breast cancer.
Cancer Drug Resist.
2022;5(3):727-748. doi: 10.20517/cdr.2022.37. eCollection 2022. Review. PubMed PMID:
36176758; PubMed Central PMCID:
PMC9511796.
Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts.
Int J Cancer.
2022 Apr 15;150(8):1329-1340. doi: 10.1002/ijc.33876. Epub 2021 Dec 2. PubMed PMID:
34792199.
Development and Validation of an Oral Cavity Cancer Outcomes Prediction Score Incorporating Patient-Derived Xenograft Engraftment.
JAMA Otolaryngol Head Neck Surg.
2022 Apr 1;148(4):342-349. doi: 10.1001/jamaoto.2022.0003. PubMed PMID:
35238880; PubMed Central PMCID:
PMC8895316.
Longitudinal health utility and symptom-toxicity trajectories in patients with head and neck cancers.
Cancer.
2022 Feb 1;128(3):497-508. doi: 10.1002/cncr.33936. Epub 2021 Oct 1. PubMed PMID:
34597435.
Monitoring and adapting cancer treatment using circulating tumor DNA kinetics: Current research, opportunities, and challenges.
Sci Adv.
2022 Jan 28;8(4):eabi8618. doi: 10.1126/sciadv.abi8618. Epub 2022 Jan 26. Review. PubMed PMID:
35080978; PubMed Central PMCID:
PMC8791609.
Prognostic importance of radiologic extranodal extension in nasopharyngeal carcinoma treated in a Canadian cohort.
Radiother Oncol.
2021 Dec;165:94-102. doi: 10.1016/j.radonc.2021.10.018. Epub 2021 Oct 27. PubMed PMID:
34718052.
Association between Genetic Variants and Cisplatin-Induced Nephrotoxicity: A Genome-Wide Approach and Validation Study.
J Pers Med.
2021 Nov 20;11(11). doi: 10.3390/jpm11111233. PubMed PMID:
34834585; PubMed Central PMCID:
PMC8623115.
HPV Sequencing Facilitates Ultrasensitive Detection of HPV Circulating Tumor DNA.
Clin Cancer Res.
2021 Nov 1;27(21):5857-5868. doi: 10.1158/1078-0432.CCR-19-2384. Epub 2021 Sep 27. PubMed PMID:
34580115; PubMed Central PMCID:
PMC9401563.
Cell-free DNA and circulating tumor cell kinetics in a pre-clinical head and neck Cancer model undergoing radiation therapy.
BMC Cancer.
2021 Oct 2;21(1):1075. doi: 10.1186/s12885-021-08791-8. PubMed PMID:
34600526; PubMed Central PMCID:
PMC8487588.
The Potential Impact and Usability of the Eighth Edition TNM Staging Classification in Oral Cavity Cancer.
Clin Oncol (R Coll Radiol).
2021 Oct;33(10):e442-e449. doi: 10.1016/j.clon.2021.05.007. Epub 2021 Jul 11. PubMed PMID:
34261594.
Antitumor immune effects of preoperative sitravatinib and nivolumab in oral cavity cancer: SNOW window-of-opportunity study.
J Immunother Cancer.
2021 Oct;9(10). doi: 10.1136/jitc-2021-003476. PubMed PMID:
34599023; PubMed Central PMCID:
PMC8488751.
Liquid Biopsy Goes Viral: Next-Generation Sequencing to Enhance HPV Detection.
Clin Cancer Res.
2021 Oct 1;27(19):5158-5160. doi: 10.1158/1078-0432.CCR-21-2180. PubMed PMID:
34301747.
Outcome and treatment toxicity in east-indian versus white-canadian patients with oral cavity cancer following postoperative (chemo-)radiotherapy delivered under similar multidisciplinary care: A propensity-matched cohort study.
Oral Oncol.
2021 Sep;120:105419. doi: 10.1016/j.oraloncology.2021.105419. Epub 2021 Jun 25. PubMed PMID:
34175612.
What would you like to do?